Literature DB >> 3539908

Abdominal aortic aneurysms: distribution of elastin, collagen I and III, and intermediate filament proteins desmin and vimentin--a comparison of familial and nonfamilial aneurysms.

L E Thornell, O Norrgård, A Eriksson, M Vanderwee, K A Angqvist.   

Abstract

The aortic walls of patients with abdominal aortic aneurysms (AAA) and of healthy controls were examined for elastin, collagen I and III, and the intermediate filament proteins desmin and vimentin by immunohistochemical, enzyme histochemical, and routine histological techniques. The morphology of the aneurysmatic walls varied considerably from case to case, but many pathological changes were seen in all cases, e.g., extensive atherosclerotic plaques in the intima, prominent alterations in amount and organization of the elastic lamellae in the media, and an increase of connective tissue. Both collagen I and III were present in all the aneurysmatic walls. The smooth muscle cells in all the aortic walls showed a marked heterogeneity with respect to the morphological appearance, the enzyme histochemical features, and the content of desmin and vimentin. Vimentin occurred in some intimal, medial muscle, and adventitial cells of both the controls and the AAA patients. Desmin occurred in some of the intimal, medial, and adventitial muscle cells of both the controls and the AAA patients. All the cells with desmin in the intima and media also contained vimentin. Thus, smooth muscle cells in the walls of both the normal human abdominal aorta and aneurysms contained either vimentin, desmin, or both. This variability may be explained by the presence of different phenotypes of smooth muscle cells and could be of significance for the development of atherosclerosis and aneurysms. Of special interest was the finding that 5 of the 24 AAA patients studied had blood relatives with the same disease, suggesting a hereditary influence. However, no systematic differences between the morphological appearance of the aneurysmatic walls in familial and nonfamilial AAA could be detected.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3539908     DOI: 10.1007/BF02128144

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  25 in total

1.  The specificity of the histochemical method for adenosine triphosphatase.

Authors:  H A PADYKULA; E HERMAN
Journal:  J Histochem Cytochem       Date:  1955-05       Impact factor: 2.479

Review 2.  What is collagen, what is not.

Authors:  S Gay; E J Miller
Journal:  Ultrastruct Pathol       Date:  1983-06       Impact factor: 1.094

3.  Familial occurrence of abdominal aortic aneurysms.

Authors:  O Norrgård; O Rais; K A Angquist
Journal:  Surgery       Date:  1984-06       Impact factor: 3.982

Review 4.  Invited review: the cellular pathobiology of atherosclerosis.

Authors:  G R Campbell; J H Chamley-Campbell
Journal:  Pathology       Date:  1981-07       Impact factor: 5.306

5.  Collagen alpha B chain: increased proportion in human atherosclerosis.

Authors:  A Ooshima
Journal:  Science       Date:  1981-08-07       Impact factor: 47.728

6.  Cytoskeletal filaments of heart conducting system localized by antibody against a 55,000 dalton protein.

Authors:  A Eriksson; L E Thornell; T Stigbrand
Journal:  Experientia       Date:  1978-06-15

7.  Vimentin-containing smooth muscle cells in aortic intimal thickening after endothelial injury.

Authors:  G Gabbiani; E Rungger-Brändle; C de Chastonay; W W Franke
Journal:  Lab Invest       Date:  1982-09       Impact factor: 5.662

8.  Aortic smooth muscle cells contain vimentin instead of desmin.

Authors:  E D Frank; L Warren
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

9.  Collagen types in neuromuscular diseases.

Authors:  H R Stephens; V C Duance; M J Dunn; A J Bailey; V Dubowitz
Journal:  J Neurol Sci       Date:  1982-01       Impact factor: 3.181

Review 10.  Intermediate filaments.

Authors:  P M Steinert; J C Jones; R D Goldman
Journal:  J Cell Biol       Date:  1984-07       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.